HRA Pharma may be about to get new owners

22 December 2015 - Deborah Wilkes

Goldman Sachs and private-equity firm Astorg Asset Management may be about to acquire control of HRA Pharma, which recently switched the ellaOne (ulipristal acetate) emergency contraceptive from prescription to non-prescription status in the European Union.